• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于酚的碳酸酐酶同工酶 I、II、IX 和 XII 的抑制剂的动力学和对接研究为酶活性位点内的新结合模式提供了证据。

Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.

机构信息

Institute for Biocomplexity and Informatics, Department of Biological Sciences, University of Calgary, Calgary, Alberta, Canada.

出版信息

Bioorg Med Chem. 2011 Feb 15;19(4):1381-9. doi: 10.1016/j.bmc.2011.01.016. Epub 2011 Jan 14.

DOI:10.1016/j.bmc.2011.01.016
PMID:21282059
Abstract

Carbonic anhydrases (CAs, EC 4.2.1.1) are inhibited by sulfonamides, inorganic anions, phenols, coumarins (acting as prodrugs) and polyamines. A novel class of CA inhibitors (CAIs), interacting with the CA isozymes I, II (cytosolic) and IX, XII (transmembrane, tumor-associated) in a different manner, is reported here. Kinetic measurements allowed us to identify hydroxy-/methoxy-substituted benzoic acids as well as di-/tri-methoxy benzenes as submicromolar-low micromolar inhibitors of the four CA isozymes. Molecular docking studies of a set of such inhibitors within CA I and II allowed us to understand the inhibition mechanism. This new class of inhibitors binds differently compared to all other classes of inhibitors known to date: they were found between the phenol-binding site and the coumarin-binding site, filling thus the middle of the enzyme cavity. They exploit different interactions with amino acid residues and water molecules from the CA active site compared to other classes of inhibitors, offering the possibility to design CAIs with an interesting inhibition profile compared to the clinically used sulfonamides/sulfamates.

摘要

碳酸酐酶(CAs,EC 4.2.1.1)可被磺胺类药物、无机阴离子、酚类、香豆素(作为前药)和多胺抑制。本文报道了一类新型碳酸酐酶抑制剂(CAIs),它们以不同的方式与 CA 同工酶 I、II(细胞溶质)和 IX、XII(跨膜,肿瘤相关)相互作用。动力学测量允许我们鉴定羟基/甲氧基取代的苯甲酸以及二/三甲氧基苯作为四种 CA 同工酶的亚微摩尔-低微摩尔抑制剂。对一组此类抑制剂在 CA I 和 II 内的分子对接研究使我们能够理解抑制机制。与迄今为止已知的所有其他类抑制剂相比,这种新型抑制剂的结合方式不同:它们位于酚结合位点和香豆素结合位点之间,从而填充了酶腔的中间部分。与其他类抑制剂相比,它们与 CA 活性位点的氨基酸残基和水分子之间存在不同的相互作用,这为设计与临床使用的磺胺类/磺胺酸盐相比具有有趣抑制谱的 CAIs 提供了可能性。

相似文献

1
Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site.基于酚的碳酸酐酶同工酶 I、II、IX 和 XII 的抑制剂的动力学和对接研究为酶活性位点内的新结合模式提供了证据。
Bioorg Med Chem. 2011 Feb 15;19(4):1381-9. doi: 10.1016/j.bmc.2011.01.016. Epub 2011 Jan 14.
2
Kinetic and in silico analysis of thiazolidin-based inhibitors of α-carbonic anhydrase isoenzymes.基于噻唑烷的α-碳酸酐酶同工酶抑制剂的动力学和计算机模拟分析。
J Enzyme Inhib Med Chem. 2013 Apr;28(2):370-4. doi: 10.3109/14756366.2012.732071. Epub 2012 Nov 23.
3
New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.新型化学型作为同工酶选择性碳酸酐酶抑制剂,对非靶标胞质同工酶 II 的亲和力低。
Bioorg Med Chem Lett. 2012 Mar 15;22(6):2182-5. doi: 10.1016/j.bmcl.2012.01.129. Epub 2012 Feb 6.
4
Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.二硫代氨基甲酸盐:一类新型碳酸酐酶抑制剂。晶体学和动力学研究。
Chem Commun (Camb). 2012 Feb 11;48(13):1868-70. doi: 10.1039/c2cc16395k. Epub 2012 Jan 5.
5
Nanoscale enzyme inhibitors: fullerenes inhibit carbonic anhydrase by occluding the active site entrance.纳米级酶抑制剂:富勒烯通过阻塞活性部位入口来抑制碳酸酐酶。
Bioorg Med Chem. 2010 Apr 15;18(8):2822-8. doi: 10.1016/j.bmc.2010.03.026. Epub 2010 Mar 15.
6
Designing of novel carbonic anhydrase inhibitors and activators.新型碳酸酐酶抑制剂和激活剂的设计。
Curr Med Chem Cardiovasc Hematol Agents. 2004 Jan;2(1):49-68.
7
Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.碳酸酐酶抑制剂:用包括对乙酰氨基酚和水杨酸在内的一系列取代酚抑制哺乳动物同工型I-XIV。
Bioorg Med Chem. 2008 Aug 1;16(15):7424-8. doi: 10.1016/j.bmc.2008.06.013. Epub 2008 Jun 13.
8
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV.单-/二羟基苯甲酸酯和酚吡啶鎓衍生物作为哺乳动物碳酸酐酶同工型 I、II、VII、IX、XII 和 XIV 的抑制剂。
Bioorg Med Chem. 2013 Mar 15;21(6):1564-9. doi: 10.1016/j.bmc.2012.05.019. Epub 2012 May 17.
9
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.碳酸酐酶抑制剂:S-取代的4-氯-2-巯基-5-甲基苯磺酰胺对人胞质同工酶I和II以及肿瘤相关同工酶IX和XII的抑制作用
Bioorg Med Chem. 2008 Apr 1;16(7):3933-40. doi: 10.1016/j.bmc.2008.01.034. Epub 2008 Jan 26.
10
Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV).碳酸酐酶抑制剂:酚类与12种具有催化活性的哺乳动物同工型(CA I-XIV)的相互作用。
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1583-7. doi: 10.1016/j.bmcl.2008.01.077. Epub 2008 Jan 26.

引用本文的文献

1
Toxicity of Three Optical Brighteners: Potential Pharmacological Targets and Effects on .三种荧光增白剂的毒性:潜在的药理学靶点及对……的影响
Toxics. 2024 Jan 9;12(1):51. doi: 10.3390/toxics12010051.
2
Repurposing of World-Approved Drugs for Potential Inhibition against Human Carbonic Anhydrase I: A Computational Study.经世界认可的药物再利用以潜在抑制人类碳酸酐rase I:计算研究。
Int J Mol Sci. 2023 Aug 9;24(16):12619. doi: 10.3390/ijms241612619.
3
The synthesis of axially disubstituted silicon phthalocyanines, their quaternized derivatives and first inhibitory effect on human cytosolic carbonic anhydrase isozymes hCA I and II.
轴向二取代硅酞菁及其季铵化衍生物的合成以及它们对人胞质碳酸酐酶同工酶hCA I和II的首次抑制作用。
RSC Adv. 2018 Mar 13;8(19):10172-10178. doi: 10.1039/c7ra13674a.
4
4-Anilinoquinazoline-based benzenesulfonamides as nanomolar inhibitors of carbonic anhydrase isoforms I, II, IX, and XII: design, synthesis, , and biological studies.基于4-苯胺基喹唑啉的苯磺酰胺作为碳酸酐酶同工酶I、II、IX和XII的纳摩尔抑制剂:设计、合成及生物学研究
J Enzyme Inhib Med Chem. 2022 Dec;37(1):994-1004. doi: 10.1080/14756366.2022.2055553.
5
Identification of Novel and Potent Indole-Based Benzenesulfonamides as Selective Human Carbonic Anhydrase II Inhibitors: Design, Synthesis, In Vitro, and In Silico Studies.鉴定新型强效吲哚基苯磺酰胺类人碳酸酐酶 II 抑制剂:设计、合成、体外和计算研究。
Int J Mol Sci. 2022 Feb 25;23(5):2540. doi: 10.3390/ijms23052540.
6
Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies.新型 2-取代苯并咪唑-6-磺酰胺类碳酸酐酶抑制剂的合成、对同工酶 I、II、IX 和 XII 的生物评价及分子对接研究。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):1697-1710. doi: 10.1080/14756366.2019.1666836.
7
Bioactive Natural Product and Superacid Chemistry for Lead Compound Identification: A Case Study of Selective hCA III and L-Type Ca Current Inhibitors for Hypotensive Agent Discovery.用于先导化合物鉴定的生物活性天然产物与超强酸化学:以用于降压药物发现的选择性hCA III和L型钙电流抑制剂为例
Molecules. 2017 May 31;22(6):915. doi: 10.3390/molecules22060915.
8
Carbonic anhydrase from Apis mellifera: purification and inhibition by pesticides.来自意大利蜜蜂的碳酸酐酶:纯化及农药抑制作用
J Enzyme Inhib Med Chem. 2017 Dec;32(1):47-50. doi: 10.1080/14756366.2016.1232255.
9
Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors.亲核试剂识别作为苯甲酸基碳酸酐酶抑制剂的替代抑制模式。
Chem Commun (Camb). 2012 May 28;48(43):5259-61. doi: 10.1039/c2cc32013d. Epub 2012 Apr 24.